DBV Technologies (DBVT) Net Margin (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Net Margin of 7200.0% for Q2 2026, down 440667.0% year-on-year from N/an in Q2 2025, and down 36.13% on a QoQ basis from 5288.89% in Q1 2026.
DBV Technologies (DBVT) Net Margin (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Net Margin for 7 consecutive years, with 7200.0% the latest figure, recorded in Q2 2026.
- Quarterly Net Margin fell 440667.0% year-over-year to 7200.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 3506.54% (down 39217.0% YoY) and the FY2025 annual result came in at 2607.29%, up 10504.0% from the prior year.
- Net Margin slipped to 7200.0% in Q2 2026 per DBVT's latest filing, from 5288.89% in the prior quarter.
- Over the last five years, Net Margin for DBVT reached as high as 3009.28% in Q4 2022 and fell as low as 7200.0% in Q2 2026.
- A 5-year average of 2298.69% and a median of 1725.15% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin soared 347558 bps — and 2026, when it slumped 440667 bps.
- Year by year, Net Margin stood at 3009.28% in 2022, then tumbled by 104 bps to 126.04% in 2023, then tumbled by 3161 bps to 4109.82% in 2024, then tumbled by 69 bps to 6950.23% in 2025, then retreated by 4 bps to 7200.0% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 7200.0%, 5288.89%, and 6950.23% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -7,200.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,200.00% |
| Mar 31, 2026 | -5,288.89% |
| Dec 31, 2025 | -6,950.23% |
| Sep 30, 2025 | -1,195.53% |
| Jun 30, 2025 | -2,793.33% |
| Mar 31, 2025 | -3,387.50% |
| Dec 31, 2024 | -4,109.82% |
| Sep 30, 2024 | -2,839.74% |
| Jun 30, 2024 | -2,852.37% |
| Mar 31, 2024 | -1,943.50% |
| Dec 31, 2023 | -126.04% |
| Sep 30, 2023 | -705.56% |
| Jun 30, 2023 | -1,059.57% |
| Mar 31, 2023 | -937.15% |
| Dec 31, 2022 | 3,009.28% |
| Sep 30, 2022 | -833.51% |
| Jun 30, 2022 | -1,506.80% |
| Mar 31, 2022 | -656.17% |
| Dec 31, 2021 | -466.30% |
| Sep 30, 2021 | -1,816.55% |